S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial
Authors:
- Young Suk ParkYPYoung Suk Park
- Ho Yeong LimHLHo Yeong Lim
- Jeeyun LeeJLJeeyun Lee
- Tae Won KimTKTae Won Kim
- Kyu-Pyo KimKKKyu-Pyo Kim
- Sun Young KimSKSun Young Kim
- Ji Yeon BaekJBJi Yeon Baek
- Jee Hyun KimJKJee Hyun Kim
- Keun-Wook LeeKLKeun-Wook Lee
- Ik-Joo ChungICIk-Joo Chung
- Sang-Hee ChoSCSang-Hee Cho
- 1 November 2012
- journal article
- research article
- Published by Elsevier in The Lancet Oncology
- Vol. 13 (11) , 1125-1132
Abstract
No abstract availableKeywords
Funding Information
- Korea Healthcare Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea (A102065)
This publication has 31 references indexed in Scilit:
- XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated resultsBritish Journal of Cancer, 2011
- A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancerBritish Journal of Cancer, 2008
- Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE StudyJournal of Clinical Oncology, 2008
- Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority studyAnnals of Oncology, 2008
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III StudyJournal of Clinical Oncology, 2008
- Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancerBritish Journal of Cancer, 2008
- A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimensBritish Journal of Cancer, 2006
- XELOX (Capecitabine Plus Oxaliplatin): Active First-Line Therapy for Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2004
- Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III StudyJournal of Clinical Oncology, 2001
- Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal CancerJournal of Clinical Oncology, 2000